CD274 and glioblastoma: Developing double-negative receptors for PD-L1 and other immunosuppressive members of the B7 family, or downregulating natively expressed receptors for these and similar molecules on the effector cell, could improve longevity or cytotoxicity of CTLs targeting HCMV on GBM.